Evidence that the human foamy virus genome is DNA

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1565-1572

  Yu, Shuyuarn F ^a   Sullivan, Mark D ^a   Linial, Maxine L ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ZIDOVUDINE;

ARTICLE; HEPATITIS B VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SPUMA VIRUS; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 0032932713     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1565-1572.1999     Document Type: Article

References (38)

1. Achong, B. G., W. A. Mansell, M. A. Epstein, and P. Clifford. 1971. An unusual virus in cultures from a human nasopharyngeal carcinoma. J. Natl. Cancer Inst. 46:299-307.
2. Arts, E. J., J. Mak, L. Kleiman, and M. A. Wainherg. 1994. DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity. J. Gen. Virol. 75:1605-1613.
3. Baldwin, D. N., and M. L. Linial. 1998. The roles of Pol and Env in the assembly pathway of human foamy virus. J. Virol. 72:3658-3665.
4. 2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70:2324-2331.
5. Bodem, J., M. Lochelt, I. Winkler, R. P. Flower, H. Delius, and R. M. Flugel. 1996. Characterisation of the spliced pol transcript of feline foamy virus - the splice acceptor site of the pol transcript is located in gag of foamy viruses. J. Virol. 70:9024-9027.
6. Bour, S., U. Schubert, K. Peden, and K. Strebel. 1996. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? J. Virol. 70:820-829.
7. Comstock, K., and M. L. Linial. Unpublished data.
8. Ganem, D., J. R. Pollack, and J. Tavis. 1994. Hepatitis B virus reverse transcriptase and its many roles in hepadnaviral genomic replication. Infect. Agents Dis. 3:85-93.
9. Giron, M.-L., S. Colas, J. Wybier, F. Rozain, and R. Emanoil-Ravier. 1997. Expression and maturation of human foamy virus Gag precursor polypeptides. J. Virol. 71:1635-1639.
10. Goff, S. P. 1990. Retroviral reverse transcriptase: synthesis, structure, and function. J. Acquir. Immune Defic. Syndr. 3:817-831.
11. Gu, Z., Q. Gao, X. Li, M. A. Parniak, and M. A. Wainberg. 1992. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine. J. Virol. 66:7128-7135.
12. Herchenroder, O., R. Turek, D. Neumann-Haefelin, A. Rethwilm, and J. Schneider. 1995. Infectious proviral clones of chimpanzee foamy virus (SKVcpz) generated by long PCR reveal close functional relatedness to human foamy virus. Virology 214:685-689.
13. Holzschu, D. L., M. A. Delaney, R. W. Renshaw, and J. W. Casey. 1998. The nucleotide sequence and spliced pol mRNA levels of the nonprimate spumavirus bovine foamy virus. J. Virol. 72:2177-2182.
14. Kogel, D., M. Aboud, and R. M. Flugel. 1995. Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease II domains. Virology 213:97-108.
15. Konvalinka, J., M. Lochelt, H. Zentgraf, R. M. Flugel, and H.-G. Krausslich. 1995. Active spumavirus proteinase is essential for virus infectivity but not for formation of the Pol polyprotein. J. Virol. 69:7264-7268.
16. Kupiec, J. J., J. Tobaly-Tapiero, M. Canivet, M. Santillana-Hayat, R. M. Flugel, J. Peries, and R. Emanoil-Ravier. 1988. Evidence for a gapped linear duplex DNA intermediate in the replicative cycle of human and simian spumaviruses. Nucleic Acids Res. 16:9557-9565.
17. Lochelt, M., and R. M. Flugel. 1996. The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J. Virol. 70:1033-1040.
18. Lochelt, M., W. Muranyi, and R. M. Flugel. 1993. Human foamy virus genome possesses an internal, bel-1 dependent and functional promoter. Proc. Natl. Acad. Sci. USA 90:7317-7321.
19. Lochelt, M., H. Zentgraf, and R. M. Flugel. 1991. Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene. Virology 184:43-54.
20. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980-982.
21. Moebes, A., J. Enssle, P. D. Bieniasz, M. Heinkelein, D. Lindemann, D. Bock, M. O. McClure, and A. Rethwilm. 1997. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol. 71:7305-7311.
22. Morozov, V. A., T. D. Copeland, K. Nagashima, M. A. Gonda, and S. Oroszlan. 1997. Protein composition and morphology of human foamy virus intracellular cores and extracellular particles. Virology 228:307-317.
23. Mullins, J. I., C. S. Chen, and E. A. Hoover. 1986. Disease specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. Nature 319:333-336.
24. Netzer, K.-O., A. Schliephake, B. Maurer, R. Watanabe, A. Aguzzi, and A. Rethwilm. 1993. Identification of pol-related gene products of human foamy virus. Virology 192:336-338.
25. Piatak, M., Jr., K.-C. Luk, B. Williams, and J. D. Lifson. 1995. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques 14:70-81.
26. Rethwilm, A. 1995. Regulation of foamy virus gene expression. Curr. Top. Microbiol. Immunol. 193:1-24.
27. Robinson, H. L., and D. M. Zinkus. 1990. Accumulation of human immunodeficiency virus type 1 DNA in T cells: results of multiple infection events. J. Virol. 64:4836-4841.
28. Santillana-Hayat, M., J. Valla, M. Canivet, J. Peries, and J. M. Molina. 1996. Inhibition of the in vitro infectivity and cytopathic effect of human foamy virus by dideoxynucleosides. AIDS Res. Hum. Retrovir. 12:1485-1490.
29. Schinazi, R. F., R. M. Lloyd, Jr., M. H. Nguyen, D. L. Cannon, A. McMillan, N. Ilksoy, C. K. Chu, D. C. Liotta, H. Z. Bazmi, and J. W. Mellors. 1993. Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. Antimicrob. Agents Chemother. 37:875-881.
30. Schweizer, M., R. Renne, and D. Neumann-Haefelin. 1989. Structural analysis of proviral DNA in simian foamy virus (LK-3)-infected cells. Arch. Virol. 109:103-114.
31. Seeger, C., and W. S. Mason. 1996. Replication of the hepatitis virus genome, p. 815-831. In M. dePamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
32. Tobaly-Tapiero, J., J. J. Kupiec, M. Santillana-Hayat, M. Canivet, J. Peries, and R. Emanoil-Ravier. 1991 Further characterization of the gapped DNA intermediates of human spumavirus: evidence for a dual initiation of plusstrand DNA synthesis. J. Gen. Virol. 72:605-608.
33. Trono, D. 1992. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J. Virol. 66:4893-4900.
34. Yee, J. K., T. Friedmann, and J. C. Burns. 1994. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43(Suppl. A):99-112.
35. Yu, S. F., D. N. Baldwin, S. R. Gwynn, S. Yendapalli, and M. L. Linial. 1996. Human foamy virus replication - a pathway distinct from that of retroviruses and hepadnaviruses. Science 271:1579-1582.
36. Yu, S. F., K. Edelmann, R. K. Strong, A. Moebes, A. Rethwilm, and M. L. Linial. 1996. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J. Virol. 70:8255-8262.
37. Yu, S. F., and M. L. Linial. 1993. Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J. Virol. 67:6618-6624.
38. Yu, S. F., J. Stone, and M. L. Linial. 1996. Productive persistent infection of hematopoietic cells by human foamy virus. J. Virol. 70:1250-1254.